急性虚血性脳卒中診断市場：製品タイプ、検査タイプ、疾患タイプ、技術、エンドユーザー別-2025-2030年の世界予測

急性虚血性脳卒中診断市場は、2023年に35億7,000万米ドルと評価され、2024年には37億7,000万米ドルに達すると予測され、CAGR 6.61％で成長し、2030年には55億9,000万米ドルに達すると予測されています。

急性虚血性脳卒中診断の対象は、主に脳への血流を制限する閉塞によって引き起こされる虚血性脳卒中患者の特定と評価です。正確かつ迅速な診断の必要性は、血流を回復させ脳の損傷を最小限に抑えるために時間が重要である脳卒中治療の緊急性に起因します。用途は救急部、病院、脳卒中専門センターにまで及び、虚血性脳卒中と出血性脳卒中を区別するためのCTやMRIスキャンなどの高度な画像診断技術に重点が置かれています。この市場は、ヘルスケア専門家、病院、研究機関、医療機器メーカーに機器や診断ツールを提供しています。成長に影響を与える主な要因としては、高齢化やライフスタイルの変化による脳卒中の有病率の増加、画像技術の進歩、ヘルスケアインフラの改善などが挙げられます。しかし、診断機器の高コストとヘルスケア格差が市場成長の制約要因となっています。市場開拓のチャンスは、携帯可能で利用しやすい診断技術の開発、早期発見のための人工知能の利用、遠隔医療、医療制度が不十分な新興国市場への進出などにあります。非侵襲的診断ツールやAIアルゴリズムの研究に投資する企業は、競争上の優位性を獲得できる可能性があります。とはいえ、専門的な労働力の必要性、規制上のハードル、AI統合に関連するデータ・プライバシーの問題などの課題に対処する必要があります。事業成長の観点からのイノベーションは、診断システムの相互運用性の強化、診断の精度とスピードの向上、デジタルヘルス新興企業との提携の模索に焦点を当てることができると思われます。市場は急速な技術進化と競争圧力によって特徴付けられ、企業は市場ポジションを維持するために継続的なイノベーションを必要としています。最適な事業成長のためには、利害関係者は戦略的提携、最先端技術への投資、特定の地域の需要に合わせた市場拡大イニシアチブを重視し、急性虚血性脳卒中診断市場の潜在的機会を最大限に活用すべきです。

市場力学：急速に進化する急性虚血性脳卒中診断市場の主要市場インサイトを公開

急性虚血性脳卒中診断市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 心筋梗塞の罹患率の増加、高度な診断ツールへのニーズの高まり
  • 発展途上地域におけるヘルスケアインフラへの投資拡大
  • タイムリーな医療介入と早期診断検査の重要性に対する意識の高まり
• 市場抑制要因
  • 発展途上地域における診断処置の高コストと高度医療へのアクセスの制限
• 市場機会
  • 高度診断のためのロボット工学とAIの統合
  • 遠隔診断と早期介入を促進する遠隔医療サービスの進歩
• 市場の課題
  • 熟練したヘルスケア専門家の不足

ポーターのファイブフォース：急性虚血性脳卒中診断市場をナビゲートする戦略ツール

ポーターのファイブフォース」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：急性虚血性脳卒中診断市場における外部からの影響の把握

外部マクロ環境要因は、急性虚血性脳卒中診断市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析急性虚血性脳卒中診断市場における競合情勢の把握

急性虚血性脳卒中診断市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス急性虚血性脳卒中診断市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、急性虚血性脳卒中診断市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨急性虚血性脳卒中診断市場における成功への道筋を描く

急性虚血性脳卒中診断市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 心臓発作の発生率が増加し、高度な診断ツールの必要性が高まる
    • 発展途上地域におけるヘルスケアインフラへの投資増加
    • タイムリーな医療介入と早期診断検査の重要性についての認識の高まり
  • 抑制要因
    • 発展途上地域では診断手順のコストが高く、高度なヘルスケアへのアクセスが限られている
  • 機会
    • 高度な診断のためのロボットとAIの統合
    • 遠隔診断と早期介入を促進する遠隔医療サービスの進歩
  • 課題
    • 熟練したヘルスケア従事者の不足
• 市場セグメンテーション分析
  • 製品タイプ：脳損傷の早期発見のための血液バイオマーカーの利用増加
  • 最終用途：集中モニタリングのための入院サービスに対するニーズの高まり
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 急性虚血性脳卒中診断市場：製品タイプ別

• 血液バイオマーカー
• 頸動脈超音波検査
• 診断画像
  • コンピュータ断層撮影（CT）スキャナ
  • MRIシステム
• 脳波検査

第7章 急性虚血性脳卒中診断市場テストタイプ別

• 画像検査
• ラボテスト
  • 血液検査
  • 代謝パネル

第8章 急性虚血性脳卒中診断市場：疾患タイプ別

• 塞栓
• ラクナー
• 血栓性

第9章 急性虚血性脳卒中診断市場：技術別

• バイオマーカーベースの検出
• ポイントオブケア検査

第10章 急性虚血性脳卒中診断市場：エンドユーザー別

• 外来手術センター
• 診断センター
• 病院
  • 入院患者
  • 外来患者
• 調査機関

第11章 南北アメリカの急性虚血性脳卒中診断市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の急性虚血性脳卒中診断市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの急性虚血性脳卒中診断市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • StrokeDx、非侵襲性脳卒中検出技術の強化と市場範囲の拡大のため500万米ドルの資金を確保
  • 中国医科大学病院のAISIA AIプラットフォームは、迅速で正確、かつ感度の高いディープラーニングモデルにより虚血性脳卒中の診断に革命をもたらし、患者の転帰を改善し、長期的なコストを削減します。
  • CERENOVUS社、TruCourseテクノロジーを搭載したCEREGLIDE 71中間カテーテルを発売、急性虚血性脳卒中治療の進歩に貢献
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• BIOTRONIK SE & Co KG
• Boehringer Ingelheim International GmbH
• Boston Scientific Corporation
• Canon Medical Systems Corporation
• F. Hoffmann-La Roche Ltd.
• Fujifilm Holdings Corporation
• GE Healthcare Technologies Inc.
• Genentech, Inc. by Roche Group
• Hitachi, Ltd.
• Integral Diagnostics（IDX）Group
• Koninklijke Philips N.V.
• Mediso Kft.
• Medtronic PLC
• Memorial Health
• Neusoft Medical Systems Co., Ltd.
• Nihon Kohden Corporation
• Planmed Oy
• Samsung Electronics Co. Ltd.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Shimadzu Corporation
• Siemens Healthineers company
• Stryker Corporation
• Toshiba International Corporation

LIST OF FIGURES

• FIGURE 1. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET RESEARCH PROCESS
• FIGURE 2. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET DYNAMICS
• TABLE 7. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY BLOOD BIOMARKER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY CAROTID ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY MRI SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY METABOLIC PANEL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY EMBOLIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LACUNAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY THROMBOTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY BIOMARKER-BASED DETECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY INPATIENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 61. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 63. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 64. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 65. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 66. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 68. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 74. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 76. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 81. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 82. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 84. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 85. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 88. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 89. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 90. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 91. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 93. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 94. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 95. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 97. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 98. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 99. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 100. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 102. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 103. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 104. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 105. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 106. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 107. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 108. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 110. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 111. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 112. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 113. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 114. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 115. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 116. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 118. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 119. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 120. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 121. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 122. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 123. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 124. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 126. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 127. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 128. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 129. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 130. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 131. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 132. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 134. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 135. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 136. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 137. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 138. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 139. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 140. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 141. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 142. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 143. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 144. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 145. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 146. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 147. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 148. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 149. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 150. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 151. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 152. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 153. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 154. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 155. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 156. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 157. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 158. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 159. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 167. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 168. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 169. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 170. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 171. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 172. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 173. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 174. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 175. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 176. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 177. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 178. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 179. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 180. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 181. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 182. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 183. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 184. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 185. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 186. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 187. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 188. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 189. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 190. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 191. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 192. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 193. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 194. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 195. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 196. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 197. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 198. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 199. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 200. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 201. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 202. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 203. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 204. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 205. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 206. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 207. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 208. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 209. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 210. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 211. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 212. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 213. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 214. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 215. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 216. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 217. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 218. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 219. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 220. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 221. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 222. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 223. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 224. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 225. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 226. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 227. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 228. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 229. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 230. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 231. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 232. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 233. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 234. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 235. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 236. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 237. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 238. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 239. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 240. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 241. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 242. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 243. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 244. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 245. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 246. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 247. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 248. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 249. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 250. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 251. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 252. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 253. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 254. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 255. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 256. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 257. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 258. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 259. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 260. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 261. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 262. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 263. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 264. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 265. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 266. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 267. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 268. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 269. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 270. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 271. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 272. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 273. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 274. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 275. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 276. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 277. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 278. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 279. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 280. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 281. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 282. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 283. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 284. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 285. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 286. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 287. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 288. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 289. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 290. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 291. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 292. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 293. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 294. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 295. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 296. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 297. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 298. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 299. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 300. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 301. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 302. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 303. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 304. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 305. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
• TABLE 306. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 307. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY LAB TESTS, 2018-2030 (USD MILLION)
• TABLE 308. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 309. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 310. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 311. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 312. SOUTH AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS M

The Acute Ischemic Stroke Diagnosis Market was valued at USD 3.57 billion in 2023, expected to reach USD 3.77 billion in 2024, and is projected to grow at a CAGR of 6.61%, to USD 5.59 billion by 2030.

The scope of acute ischemic stroke diagnosis involves identifying and evaluating patients experiencing ischemic strokes, primarily caused by blockages restricting blood flow to the brain. The necessity for accurate and rapid diagnosis stems from the urgent nature of stroke treatment, where time is critical to restore blood flow and minimize brain damage. The applications extend to emergency departments, hospitals, and specialized stroke centers, focusing on advanced imaging technologies like CT and MRI scans to differentiate between ischemic and hemorrhagic strokes. This market serves healthcare professionals, hospitals, research institutions, and medical device manufacturers with equipment and diagnostic tools. Key factors influencing growth include the increasing prevalence of strokes due to aging populations and lifestyle changes, advancements in imaging technology, and improved healthcare infrastructure. However, the high cost of diagnostic equipment and healthcare disparities pose limitations to market growth. Opportunities lie in the development of portable and accessible diagnostic technologies, use of artificial intelligence for early detection, telemedicine, and expansion into emerging markets with inadequate healthcare systems. Companies investing in research for non-invasive diagnostic tools and AI algorithms may gain competitive advantages. Nonetheless, challenges such as the need for specialized workforce, regulatory hurdles, and data privacy issues related to AI integration must be addressed. Innovation from a business growth perspective could focus on enhancing the interoperability of diagnostic systems, improving accuracy and speed of diagnosis, and exploring partnerships with digital health startups. The market is characterized by rapid technological evolution and competitive pressures requiring companies to continuously innovate to maintain market positions. For optimal business growth, stakeholders should emphasize strategic collaborations, investment in cutting-edge technologies, and market expansion initiatives tailored to specific regional demands to harness the full potential of opportunities in the acute ischemic stroke diagnosis market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Acute Ischemic Stroke Diagnosis Market

The Acute Ischemic Stroke Diagnosis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidence of cardiac strokes, enhancing need for advanced diagnostic tools
  • Growing investment in healthcare infrastructure in developing regions
  • Rising awareness about the importance of timely medical intervention and earlier diagnostic testing
• Market Restraints
  • High cost of diagnostic procedures and limited access to advanced healthcare in developing regions
• Market Opportunities
  • Integration of robotics and AI for advanced diagnostics
  • Advancement in telemedicine services facilitating remote diagnosis and early intervention
• Market Challenges
  • Shortage of skilled healthcare professionals

Porter's Five Forces: A Strategic Tool for Navigating the Acute Ischemic Stroke Diagnosis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Acute Ischemic Stroke Diagnosis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Acute Ischemic Stroke Diagnosis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Acute Ischemic Stroke Diagnosis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Acute Ischemic Stroke Diagnosis Market

A detailed market share analysis in the Acute Ischemic Stroke Diagnosis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Acute Ischemic Stroke Diagnosis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Acute Ischemic Stroke Diagnosis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Acute Ischemic Stroke Diagnosis Market

A strategic analysis of the Acute Ischemic Stroke Diagnosis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Acute Ischemic Stroke Diagnosis Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BIOTRONIK SE & Co KG, Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Canon Medical Systems Corporation, F. Hoffmann-La Roche Ltd., Fujifilm Holdings Corporation, GE Healthcare Technologies Inc., Genentech, Inc. by Roche Group, Hitachi, Ltd., Integral Diagnostics (IDX) Group, Koninklijke Philips N.V., Mediso Kft., Medtronic PLC, Memorial Health, Neusoft Medical Systems Co., Ltd., Nihon Kohden Corporation, Planmed Oy, Samsung Electronics Co. Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shimadzu Corporation, Siemens Healthineers company, Stryker Corporation, and Toshiba International Corporation.

Market Segmentation & Coverage

This research report categorizes the Acute Ischemic Stroke Diagnosis Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Blood Biomarker, Carotid Ultrasound, Diagnostic Imaging, and Electroencephalography. The Diagnostic Imaging is further studied across Computed Tomography (CT) Scanner and MRI System.
• Based on Test Type, market is studied across Imaging Tests and Lab Tests. The Lab Tests is further studied across Blood Test and Metabolic Panel.
• Based on Disease Type, market is studied across Embolic, Lacunar, and Thrombotic.
• Based on Technology, market is studied across Biomarker-Based Detection and Point Of Care Testing.
• Based on End Users, market is studied across Ambulatory Surgical Centers, Diagnostic Centers, Hospitals, and Research Institutes. The Hospitals is further studied across Inpatient and Outpatient.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidence of cardiac strokes, enhancing need for advanced diagnostic tools
    • 5.1.1.2. Growing investment in healthcare infrastructure in developing regions
    • 5.1.1.3. Rising awareness about the importance of timely medical intervention and earlier diagnostic testing
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of diagnostic procedures and limited access to advanced healthcare in developing regions
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of robotics and AI for advanced diagnostics
    • 5.1.3.2. Advancement in telemedicine services facilitating remote diagnosis and early intervention
  • 5.1.4. Challenges
    • 5.1.4.1. Shortage of skilled healthcare professionals
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Growing usage of blood biomarkers for early detection of brain injury
  • 5.2.2. End Use: Rising need of inpatient services for intensive monitoring
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Acute Ischemic Stroke Diagnosis Market, by Product Type

• 6.1. Introduction
• 6.2. Blood Biomarker
• 6.3. Carotid Ultrasound
• 6.4. Diagnostic Imaging
  • 6.4.1. Computed Tomography (CT) Scanner
  • 6.4.2. MRI System
• 6.5. Electroencephalography

7. Acute Ischemic Stroke Diagnosis Market, by Test Type

• 7.1. Introduction
• 7.2. Imaging Tests
• 7.3. Lab Tests
  • 7.3.1. Blood Test
  • 7.3.2. Metabolic Panel

8. Acute Ischemic Stroke Diagnosis Market, by Disease Type

• 8.1. Introduction
• 8.2. Embolic
• 8.3. Lacunar
• 8.4. Thrombotic

9. Acute Ischemic Stroke Diagnosis Market, by Technology

• 9.1. Introduction
• 9.2. Biomarker-Based Detection
• 9.3. Point Of Care Testing

10. Acute Ischemic Stroke Diagnosis Market, by End Users

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Diagnostic Centers
• 10.4. Hospitals
  • 10.4.1. Inpatient
  • 10.4.2. Outpatient
• 10.5. Research Institutes

11. Americas Acute Ischemic Stroke Diagnosis Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Acute Ischemic Stroke Diagnosis Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Acute Ischemic Stroke Diagnosis Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. StrokeDx secures USD 5M funding to enhance non-invasive stroke detection technology and expand market reach
  • 14.3.2. China Medical University Hospital's AISIA AI platform revolutionizes ischemic stroke diagnosis with rapid, accurate, and sensitive deep learning models, enhancing patient outcomes and reducing long-term costs
  • 14.3.3. CERENOVUS launches CEREGLIDE 71 Intermediate Catheter with TruCourse technology, advancing acute ischemic stroke treatment
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. BIOTRONIK SE & Co KG
• 3. Boehringer Ingelheim International GmbH
• 4. Boston Scientific Corporation
• 5. Canon Medical Systems Corporation
• 6. F. Hoffmann-La Roche Ltd.
• 7. Fujifilm Holdings Corporation
• 8. GE Healthcare Technologies Inc.
• 9. Genentech, Inc. by Roche Group
• 10. Hitachi, Ltd.
• 11. Integral Diagnostics (IDX) Group
• 12. Koninklijke Philips N.V.
• 13. Mediso Kft.
• 14. Medtronic PLC
• 15. Memorial Health
• 16. Neusoft Medical Systems Co., Ltd.
• 17. Nihon Kohden Corporation
• 18. Planmed Oy
• 19. Samsung Electronics Co. Ltd.
• 20. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 21. Shimadzu Corporation
• 22. Siemens Healthineers company
• 23. Stryker Corporation
• 24. Toshiba International Corporation